Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
23.40
-1.69 (-6.74%)
May 13, 2025, 4:00 PM - Market closed
Pacira BioSciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -103.73 | -99.56 | 41.96 | 15.91 | 41.98 | 145.52 | Upgrade
|
| Depreciation & Amortization | 81.53 | 78.79 | 75.57 | 81 | 28.55 | 19.91 | Upgrade
|
| Other Amortization | 3.38 | 3.22 | 3.75 | 7.21 | 25.91 | 20.41 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 163.24 | 163.24 | - | 36.63 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 10 | - | -1.62 | Upgrade
|
| Stock-Based Compensation | 52.57 | 51.17 | 47.9 | 48.09 | 42.25 | 39.92 | Upgrade
|
| Other Operating Activities | 4.15 | 11.05 | 31.25 | -37.14 | 12.55 | -113.34 | Upgrade
|
| Change in Accounts Receivable | -3.11 | -7.75 | -7.16 | -2.08 | -10.43 | -5.52 | Upgrade
|
| Change in Inventory | -36.97 | -20.93 | -8.29 | 2.49 | -4.47 | -6.35 | Upgrade
|
| Change in Accounts Payable | 12.52 | 3.08 | 0.92 | 6.27 | -10.26 | -3.31 | Upgrade
|
| Change in Other Net Operating Assets | 2.15 | 7.07 | -31.24 | -23.11 | -0.35 | -18.61 | Upgrade
|
| Operating Cash Flow | 175.75 | 189.39 | 154.65 | 145.27 | 125.72 | 77.03 | Upgrade
|
| Operating Cash Flow Growth | -4.81% | 22.46% | 6.45% | 15.56% | 63.20% | 9.23% | Upgrade
|
| Capital Expenditures | -16.35 | -10.64 | -15.16 | -30.08 | -45.87 | -37.8 | Upgrade
|
| Cash Acquisitions | -16.7 | - | - | -32 | -424.04 | - | Upgrade
|
| Investment in Securities | -60.33 | -72.64 | 92.7 | -163.11 | 449.12 | -239.81 | Upgrade
|
| Investing Cash Flow | -93.38 | -83.28 | 77.54 | -225.19 | -20.79 | -277.61 | Upgrade
|
| Long-Term Debt Issued | - | 287.5 | 149.55 | - | 363.75 | 314.71 | Upgrade
|
| Long-Term Debt Repaid | - | -210.89 | -330.31 | -427.69 | - | -176.79 | Upgrade
|
| Net Debt Issued (Repaid) | 76.62 | 76.62 | -180.76 | -427.69 | 363.75 | 137.92 | Upgrade
|
| Issuance of Common Stock | 2.3 | 2.3 | 4.75 | 27.34 | 26.66 | 135.56 | Upgrade
|
| Repurchase of Common Stock | -25.67 | -25.49 | -0.11 | - | - | -33.09 | Upgrade
|
| Other Financing Activities | -36.06 | -36.06 | -6.91 | -1.18 | -9.71 | -18.08 | Upgrade
|
| Financing Cash Flow | 17.19 | 17.36 | -183.03 | -401.53 | 380.69 | 222.3 | Upgrade
|
| Net Cash Flow | 99.56 | 123.48 | 49.16 | -481.44 | 485.62 | 21.73 | Upgrade
|
| Free Cash Flow | 159.4 | 178.75 | 139.49 | 115.2 | 79.85 | 39.23 | Upgrade
|
| Free Cash Flow Growth | -7.96% | 28.15% | 21.09% | 44.27% | 103.54% | -35.01% | Upgrade
|
| Free Cash Flow Margin | 22.68% | 25.50% | 20.67% | 17.28% | 14.74% | 9.13% | Upgrade
|
| Free Cash Flow Per Share | 3.45 | 3.87 | 2.68 | 2.48 | 1.75 | 0.90 | Upgrade
|
| Cash Interest Paid | 14.16 | 15.42 | 27.64 | 33.3 | 7 | 7.21 | Upgrade
|
| Cash Income Tax Paid | 11.55 | 11.02 | 4.37 | 7.4 | 3.22 | 2.42 | Upgrade
|
| Levered Free Cash Flow | 144.75 | 163.38 | 107.15 | 92 | 49.79 | 38.75 | Upgrade
|
| Unlevered Free Cash Flow | 152.51 | 170.52 | 116.09 | 109.78 | 43.72 | 34.39 | Upgrade
|
| Change in Net Working Capital | 21.67 | 9.79 | 46.79 | 33.57 | 37.41 | 19.84 | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.